Large-scale trials in intensive care

The economic value of large-scale clinical trials in intensive care – Steve Webb

Large-scale clinical trials are expensive and take years to go. Do they generate patient and economic benefit that justifies the cost of trials?

The Podcast
The Slides

Steve splits his time between being an intensivist at Royal Perth Hospital and doing clinical trials. He is a former chair of the ANZICS CTG and has published more than 150 manuscripts including several major ANZICS trials. Steve has been involved in formation of the Australian Clinical Trials Alliance (ACTA), which represents trial networks across all disciplines, ACTA seeks better ways of doing trials to improve patient outcomes.

The Coda Community

Coda is a community tackling the most urgent healthcare challenges, that need action, now. Join the Coda community or online at FacebookTwitterInstagram, or Linkedin

CODA22: Melbourne from 3-6 April 2022, will be an unparalleled healthcare event guaranteed to inspire your practice




Oliver Flower, staff specialist in Intensive Care Medicine at Royal North Shore Hospital, Sydney | NeuroResus |

One comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.